| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.21 | 5e-06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |